At our practice, we are proud to offer the latest light therapy technologies for treating dry eye disease. Our state-of-the-art OptiLight device can help improve the quality of your vision by restoring moisture to your eyes.
The OptiLight is the only FDA-approved light therapy (IPL) for managing dry eye disease due to MGD (meibomian gland deficiency). The OptiLight uses precise broad-spectrum light to address signs of dry eye disease caused by MGD, the most common cause of dry eye. The OptiLight is a precise and comfortable dry eye procedure developed to reach the delicate contours below the eye and reduce inflammation.
The treatment is facilitated in 4 sessions spaced 2–4 weeks apart; each session only takes 10–15 minutes. During treatment, your doctor will cover your eyes with a protective shield and apply a thin layer of gel on the treatment area. Then, the OptiLight is applied to the skin below the eyes. The treatment is non-invasive, you’ll feel a warm sensation of light with minimal discomfort. Most patients can return to regular activities after treatment and expect to see improvement after the 2nd or 3rd session.
If you are interested in learning more about our advanced light therapy options and how they can benefit you, we encourage you to contact our office today. Our team would be more than happy to answer any questions you may have and help you determine if this treatment option is right for you. We look forward to hearing from you soon!
